Lv5
1346 积分 2024-11-12 加入
Expert consensus on the clinical application of TROP2-targeted antibody-drug conjugates in non-small cell lung cancer (2026 edition
1个月前
已完结
Expert consensus on the clinical application of TROP2-targeted antibody-drug conjugates in non-small cell lung cancer (2026 edition)
1个月前
已完结
The potential of antibody-drug conjugates in immunotherapy for non-small cell lung cancer: current progress and future
5个月前
已完结
Tumour and microenvironment crosstalk in NSCLC progression and response to therapy
5个月前
已完结
Leveraging TROP2 Antibody-Drug Conjugates in Solid Tumors
6个月前
已完结
TROP2 ADC Intrigues in NSCLC
6个月前
已完结
TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC)
6个月前
已完结
TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC
6个月前
已完结
Targeting Lung Cancer with Precision: The ADC Therapeutic Revolution
6个月前
已完结
Recent advances in therapeutic strategies for non-small cell lung cancer
6个月前
已完结
皖公网安备34019202002308
